Atypical Cellular Disorders
Open Access
- 1 January 2004
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2004 (1) , 283-296
- https://doi.org/10.1182/asheducation-2004.1.283
Abstract
Some immunologic diseases are characterized by profound loss or primary dysfunction of a given population of cells. The atypical cellular disorders discussed here all bear some similarities in that abnormal proliferations of lymphocytes and macrophages or dendritic cells result in lymphadenopathy, skin rashes, bone lesions and infiltrations of nearly any other organ system. What are the similarities and the differences between Langerhans cell histiocytosis (LCH), sinus histiocytosis with massive lymphadenopathy (SHML) or Rosai-Dorfman disease, and Castleman’s disease (CD)? Studies on LCH have some advantages since it was described before the others, and organized clinical trials have been done since the 1980s. The understanding of SHML benefited from a registry maintained by Drs. Rosai and Dorfman. CD was described fifty years ago and for one subtype has the most clearly defined etiology (HHV-8 infection) of the three atypical cellular disorders discussed here.Keywords
This publication has 70 references indexed in Scilit:
- Efficacy of continuous infusion 2‐CDA (cladribine) in pediatric patients with Langerhans cell histiocytosisPediatric Blood & Cancer, 2004
- Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosisPediatric Blood & Cancer, 2004
- Extranodal Rosai-Dorfman Disease in ChildrenJournal of Pediatric Hematology/Oncology, 2004
- Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoterMedical and Pediatric Oncology, 2003
- Pattern and course of single‐system disease in Langerhans cell histiocytosis data from the DAL‐HX 83‐ and 90‐studyMedical and Pediatric Oncology, 2001
- Perforin Gene Defects in Familial Hemophagocytic LymphohistiocytosisScience, 1999
- Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's diseaseBritish Journal of Haematology, 1999
- Expression of Human Herpesvirus-6 Antigens in Benign and Malignant Lymphoproliferative DiseasesThe American Journal of Pathology, 1998
- Is cutaneous plasmacytosis a distinct clinical entity?Journal of the American Academy of Dermatology, 1997
- Angiofollicular lymph node hyperplasia (Castleman's disease)Cancer Treatment Reviews, 1995